|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,712,016 |
|
|
Indirect Value
|
$63,973 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-05-15 |
4 |
AS |
$276.35 |
$32,089 |
D/D |
(113) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-07-07 |
4 |
AS |
$300.00 |
$835,800 |
D/D |
(2,786) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-08-03 |
4 |
AS |
$276.40 |
$432,337 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-11-03 |
4 |
AS |
$210.56 |
$329,115 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-11-16 |
4 |
AS |
$222.47 |
$1,565 |
D/D |
(7) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-06-19 |
4 |
OE |
$131.89 |
$280,266 |
D/D |
2,125 |
35,365 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-08-08 |
4 |
OE |
$131.89 |
$280,266 |
D/D |
2,125 |
35,365 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-05-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
35,395 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-04 |
4 |
AS |
$184.81 |
$3,409,082 |
D/D |
(18,309) |
36,402 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2013-12-12 |
4 |
AS |
$65.47 |
$197,785 |
D/D |
(3,021) |
36,718 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-05-04 |
4 |
OE |
$86.52 |
$134,366 |
D/D |
1,553 |
36,732 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-08-03 |
4 |
OE |
$86.52 |
$134,366 |
D/D |
1,553 |
36,732 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-11-03 |
4 |
OE |
$86.52 |
$134,366 |
D/D |
1,553 |
36,732 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-03 |
4 |
OE |
$86.52 |
$330,756 |
D/D |
3,710 |
36,950 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-01-31 |
4 |
OE |
$187.53 |
$879,891 |
D/D |
4,692 |
37,932 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-07-07 |
4 |
OE |
$155.57 |
$483,403 |
D/D |
2,786 |
37,965 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-24 |
4 |
D |
$239.23 |
$693,289 |
D/D |
(2,898) |
38,813 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-02-11 |
4 |
AS |
$179.44 |
$5,959,969 |
D/D |
(33,073) |
38,864 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2013-10-01 |
4 |
AS |
$75.73 |
$947,166 |
D/D |
(12,417) |
39,334 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2012-09-04 |
4 |
A |
$0.01 |
$397 |
D/D |
39,667 |
39,667 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-25 |
4 |
AS |
$211.39 |
$775,989 |
D/D |
(3,634) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Comm & Ops Officer |
|
2021-05-17 |
4 |
AS |
$215.33 |
$23,589 |
D/D |
(109) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2021-11-15 |
4 |
AS |
$186.99 |
$562 |
D/D |
(3) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-18 |
4 |
AS |
$242.08 |
$761,842 |
D/D |
(3,128) |
41,711 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-10-31 |
4 |
AS |
$142.18 |
$10,860,645 |
D/D |
(75,000) |
41,952 |
0 |
- |
|
192 Records found
|
|
Page 2 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|